Search results
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman via Yahoo News· 54 minutes agoThe Centers for Disease Control and Prevention recommends everyone 6 months and older get an updated...
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? - BioNTech (NASDAQ:BNTX)
Benzinga· 4 days agoBioNTech SE’s BNTX partner MediLink Therapeutics (Suzhou) Co., Ltd says the FDA has placed a partial clinical hold on the Phase 1 trial. The MediLink-sponsored trial evaluates ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 17 hours agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
Insider Monkey via Yahoo Finance· 4 days agoRGA Investment Advisors, an investment management company released its first quarter 2024 investor...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 3 days agoFood and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 1 day agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit By Reuters
Investing.com· 4 days agoIn a lawsuit filed in the District Court of Thomas County, the state said the New York-based...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 7 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Moderna stock is lone omen of bird flu pandemic
Reuters· 4 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...